Escolar Documentos
Profissional Documentos
Cultura Documentos
Antiepileptic Drugs
Department of Pharmacology
Zhang Xiaojie
Epilepsy
Epilepsy is a heterogeneous symptom
complex, a chronic disorder characterized
by sudden, transient and recurrent seizures
which are episodes of brain dysfunction
resulting from abnormal discharge of focal
cerebral neuron and diffusion to normal
neuronal tissues.
Pathogenesis
Normal neurons
Epileptic focal
Abnormal highfrequency discharge
sudden, excessive and abnormal high-frequency discharge of
neurons diffuses to local or whole brain in a short time
over-excitement brain dysfunction
Epilepsy
Etiology incidence: 50/100,000
Primary epilepsy:
30%
inherited abnormality
Secondary epilepsy: 70%
Classifications
Partial seizures
(1)Simple partial seizures
2. Generalized seizures
(1)Absence seizures (petit mal)
(2)Myoclonic seizures
1.
Partial seizures
(1) Simple partial
Do not lose consciousness and often
exhibit abnormal activity of a single limb
or muscle group, lasting 20-60s
Key feature: preservation of
consciousness
Partial seizures
(2) Complex partial
Exhibit motor dysfunction and impaired
consciousness lasting 30s-2m,often
associated with purposeless movents
Generalized seizures
(1) Generalized tonic-clonic seizures
Loss of consciousness and sustained
contractions(tonic) of muscles followed by
periods of contraction and relaxation (clonic),
typically lasting 1-2m
Continuous episodes with sustained loss of
consciousness is called status epilepticus .
Generalized seizures
(2) Absence seizure
Involve a brief, sudden and selflimiting loss of consciousness. The
patient stare and exhibits rapid eyeblinking, which lasts for 3 to 5
seconds without any motor disorder.
Generalized seizures
(3) Myoclonic
a brief (perhaps a second), shocklike
contraction of muscles which may be
restricted to part of one extremity or
may be generalized
Mechanism of Action
A few drugs appear to act by a third mechanism,
namely inhibition of T-type calcium channels.
Newer drugs act by other mechanism, yet to be
elucidated.
Drugs that block excitatory amino acid receptors
are effective in animal models, but not yet
developed for clinical use.
Phenytoin (dilantin)
Mechanism of Action: acts by stabilizing membranes
(1) Blocking the voltage-dependence Na+ channel,
limiting the repetitive firing of action potentials
(2) Blocking voltage-dependence Ca2+ channel (L , N)
(3) Inhibiting calcium-induced secretory processes,
including release of hormones and
neurotransmitters.
PHARMACOKINETICS
Because phenytoin is a weak alkali, its
absorption is slow and unpredictable after oral
administration and plasma concentration can
vary widely. Monitoring is therefore needed
It is metabolized by the microsomal system
and is excreted first in the bile and then in the
urine.
Clinical uses
1.Epilepsy:
all epilepsies but absence seizure
Clinical uses
2. Treatment of peripheral neuralgia :
trigeminal neuralgia et al
3. Antiarrhythmias ventricular
arrhythmias
First choice for ventricular arrhythmias caused by
cardiac glycoside intoxication
Adverse Reactions
1. Gastrointestinal reaction
2. Gingival hyperplasia by increasing the
Adverse Reactions
3. CNS symptoms
20g/ml drowsiness, dizziness,
ataxia, 40g/ml: psychotic,
50g/ml: coma
4. Blood system:
folic acid deficiency
Megaloblastic anemia
Add leucovorin
Adverse Reactions
5. Bone system
hypocalcemia, osteomalacia, rachitis
reason increase the metabolism of vitamin D
Carbamazepine
Broadspectrum antiepileptic agent
Mechanisms (similar to phenytoin.)
Carbamazepine
Actions and Uses
1. Antiepileptic effects
grad mal, partial seizures with complex
symptomatology first choice
2. Central algesia: trigeminal neuralgia
more effective than phenytoin
3. Mania and depression
4. diabetes insipidus
Adverse Reactions
1. Gastrointestinal reaction
2. CNS reactions: drowsness, vertigo,
nausea, vomit, ataxia
3. Blood system: leukopenia ,
agranulocytosis ,
thrombocytopenia ,
aplastic anemia
4. Hepatic intoxication
Phenobarbital
Luminal
Broad-spectrum and much effective
in grad mal and partial seizures, but
not drug choice for grad mal, alternative
and iv in the treatment of status
epilepticus
Mechanisms
1. Potentiate the GABA inhibitory
Ca2+
Neurotransmitter
Ethosuximide
The only indication: absence epilepsy
Mechanisms:
1. reducing the T-type Ca2+ current
2. inhibiting GABA aminotransferase(
) Na+-K+-ATP
Adverse Reactions
1. Gastric distress
2. CNS distress
3. Blood system agranulocytosis,
Sodium Valproate
Broadspectrum antiepileptic agent
Mechanisms:
1.potentiate GABA function
inhibit GABA-T
increase the activity of GAD
2.inhibit Na+ channel
3.inhibit L-Ca2+ channel
inhibit T-Ca2+ channel
uses
Effective for all types of epilepsy,
more effective than ethosuxide for absence
less effective for grad mal and partial mal
grad mal combine with absence seizures
first choice
Adverse Reactions
1. Hepatic intoxication
2. CNS and blood system
thrombocytopenia
3. Teratogenesis
Benzodiazepines
1. Diazepam :first choice for status
epilepticus by iv
2. Nitrazepam : myoclonic
seizure, atypical absence seizure and
infantile spasm
3. Clonazepam: absence seizure, atonic
and akinetic seizures
treatment of seizures